KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.

Hearts, Free Full-Text

A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young

Sensors, Free Full-Text

Implementation of a fully remote randomized clinical trial with cardiac monitoring

AliveCor gains US FDA clearance for KardiaMobile 6L to calculate patients' QTc interval - Medical Device News by Guided Solutions

RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement - Lenihan - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library

2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library

Using 12-Lead ECG to Detect Drug-Induced Long QT Interval: The Gold Standard

AliveCor Kardia Mobile 6L FDA Cleared- Mobile ECG Device, New

AliveCor KardiaMobile (Malaysia) – BioD Medica

Carrying case for AliveCor KardiaMobile 6L - Travel Case Fits in Pocket for AliveCor, Features Magnetic Closure to Keep Kardia EKG Monitor Safe On The Go Dark Blue

What to do if I see a Connect to your KardiaMobile 6L error when I am trying to record? – AliveCor Support

KardiaMobile EKG Monitor - Instant EKG on Your Phone